Polycystic Ovarian Syndrome: Evaluating the optimal therap
| dc.contributor.author | Ellafi, Abdelmuaz | |
| dc.date.accessioned | 2020-09-26T11:40:44Z | |
| dc.date.available | 2020-09-26T11:40:44Z | |
| dc.date.issued | 2020-10-03 | |
| dc.description | Polycystic Ovarian Syndrome, formerly called (Stein-Leventhal syndrome) is a heterogeneous and complex disorder that has adverse reproductive and metabolic implications for affected women. This disorder has an unclear etiology1. The most accurate and widely accepted clinical definition of PCOS is the association of hyperandrogenism with chronic anovulation in women without an underlying disease of pituitary or adrenal glands, along with the presence of polycystic ovaries. If two of these three criteria were present then the patient can be diagnosed with PCOS2. PCOS affects 5-10% of women of reproductive age. Hyperandrogenism is characterized clinically by hirsutism, acne, and androgen-dependent alopecia and biochemically by elevated serum concentrations of androgens, particularly testosterone and androstenedione | en_US |
| dc.description.abstract | This report reviews the treatment of Polycystic Ovarian Syndrome (PCOS) and early diagnosis helps in the effective treatment. Polycystic ovarian syndrome affects women's ovulation and also leads to infertility. Treatment-resistant acne and acanthosis nigricans are symptoms for this disorder. A number of cases have discussed this issue thoroughly and results concluded that dietary changes, metformin and clomiphene are all effective ways in the treatment of this disorder | en_US |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/1998 | |
| dc.language.iso | en | en_US |
| dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title | Polycystic Ovarian Syndrome: Evaluating the optimal therap | en_US |
| dc.type | Other | en_US |